The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial

INTRODUCTION: The progressive nature of type 2 diabetes necessitates treatment intensification. This often involves intensification with oral antidiabetic drugs (OADs) initially, followed by other agents, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs), with the majority of patients eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Linjawi, Sultan, Bode, Bruce W., Chaykin, Louis B., Courrèges, Jean-Pierre, Handelsman, Yehuda, Lehmann, Lucine M., Mishra, Abhishek, Simpson, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306117/
https://www.ncbi.nlm.nih.gov/pubmed/27943107
http://dx.doi.org/10.1007/s13300-016-0218-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306117/
https://www.ncbi.nlm.nih.gov/pubmed/27943107
http://dx.doi.org/10.1007/s13300-016-0218-3

Ejemplares similares